Edition:
United Kingdom

Recipharm AB (publ) (RECIb.ST)

RECIb.ST on Stockholm Stock Exchange

133.20SEK
4:29pm BST
Change (% chg)

-2.60kr (-1.91%)
Prev Close
135.80kr
Open
135.20kr
Day's High
138.20kr
Day's Low
132.40kr
Volume
155,862
Avg. Vol
141,912
52-wk High
168.00kr
52-wk Low
82.80kr

Latest Key Developments (Source: Significant Developments)

Recipharm Q2 EBITDA Rises To SEK 307 Million
Wednesday, 25 Jul 2018 

July 25 (Reuters) - RECIPHARM AB (PUBL) ::APRIL - JUNE 2018* NET SALES AMOUNTED TO SEK 1,701 MILLION (1,401), AN INCREASE OF 21%.Q2 EBITDA SEK 307 MILLION VERSUS SEK 242 MILLION YEAR AGO.  Full Article

Recipharm Partners With Hadasit
Tuesday, 15 May 2018 

May 15 (Reuters) - RECIPHARM AB (PUBL) ::RECIPHARM AND HADASIT PARTNER TO DELIVER SEAMLESS CHEMICAL AND CLINICAL SERVICES.PARTNERED WITH HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT TO OFFER COMBINED CLINICAL, BIOLOGICAL AND CHEMICAL SERVICES..  Full Article

Recipharm Buys Remaining Shares In Nitin Lifesciences
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Recipharm Ab (Publ) ::RECIPHARM ACQUIRES REMAINING SHARES IN NITIN LIFESCIENCES LTD.RECIPHARM AB (PUBL) - CONSIDERATION IS INR 2,800 MILLION (SEK 351 MILLION1).RECIPHARM AB (PUBL) - REACHED AN AGREEMENT TO ACQUIRE REMAINING 26 PER CENT OF SHARES OF NITIN LIFESCIENCES LIMITED.RECIPHARM AB (PUBL) - INR 600 MILLION (SEK 75 MILLION1) WILL BE PAID IN NEWLY ISSUED RECIPHARM SHARES (RECI-B).  Full Article

Recipharm Q3 EBITDA down at SEK ‍103​ mln
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - RECIPHARM AB (PUBL) :Q3 NET SALES SEK ‍1.20 BILLION VERSUS SEK 1.14 BILLION YEAR AGO.Q3 EBITDA SEK ‍103​ MILLION VERSUS SEK 144 MILLION YEAR AGO.  Full Article

Recipharm Q3 EBITDA down at SEK ‍103​ mln
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - RECIPHARM AB (PUBL) ::Q3 EBITDA SEK ‍103​ MILLION VERSUS SEK 144 MILLION YEAR AGO.Q3 NET SALES SEK ‍1.20​ BILLION VERSUS SEK 1.14 BILLION YEAR AGO.  Full Article

Recipharm to end operations in two facilities in Sweden
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - RECIPHARM AB (PUBL) ::RECIPHARM TO END OPERATIONS IN TWO FACILITIES IN SWEDEN.‍TO START A PROCESS WITH INTENTION OF DISCONTINUING ACTIVITIES BOTH IN STOCKHOLM AND HÖGANÄS.​.‍WILL EXPLORE OPPORTUNITY TO CLOSE FACILITIES DURING SECOND HALF OF 2019​.SAYS ‍WILL EVALUATE DIFFERENT OPTIONS FOR FACILITY SUCH AS DIVESTMENT OF MANUFACTURING SITE​.‍FINAL DECISION REGARDING DISCONTINUED MANUFACTURING OPERATIONS IN STOCKHOLM AND HÖGANÄS TO BE MADE BEFORE END-2017.‍CLOSURE AFFECTS APPROXIMATELY 225 OF SWEDISH EMPLOYEES​.‍WILL EXPLORE OPPORTUNITY TO CLOSE FACILITIES IN GREATER STOCKHOLM AREA DURING SECOND HALF OF 2019​.‍ESTIMATED NON-RECURRING COSTS ASSOCIATED WITH DECISION TO DISCONTINUE OPERATIONS ARE EXPECTED TO BE CHARGED TO Q4​.‍ESTIMATED NON-RECURRING COSTS ASSOCIATED WITH DECISION TO BE CHARGED TO Q4 RESULTS​.  Full Article

Recipharm says Chief Financial Officer to leave company
Monday, 19 Dec 2016 

Recipharm Ab (Publ) : Says Chief Financial Officer to leave recipharm .Says a search process has commenced to appoint a new CFO..  Full Article

BRIEF-Recipharm Q1 EBITDA Up At SEK 250 Million

* Q1 NET SALES SEK 1.51 BILLION VERSUS SEK 1.33 BILLION YEAR AGO